Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts

Completed · Not applicable

Conditions studied: Symptomatic Ischemic Saphenous Vein Graft Disease

In brief

The objective of the Symbiot III Clinical Trial was to evaluate the safety and effectiveness of the Symbiot Covered Stent System in the treatment of symptomatic ischemic saphenous vein bypass graft disease.

Key facts

Study ID
NCT00283413
Run by
Boston Scientific Corporation
People needed
514
Starts
2002-03-01
Expected to finish
2009-03-01
Last updated by the study team
2009-11-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.